Response to: GCP III is not the "off-target" for urea-based PSMA-ligands.

Bassi, Gabriele; Cazzamalli, Samuele; Oehler, Sebastian; Lucaroni, Laura; Georgiev, Tony; Favalli, Nicholas; Neri, Dario

Bassi, Gabriele; Cazzamalli, Samuele; Oehler, Sebastian; Lucaroni, Laura; Georgiev, Tony; Favalli, Nicholas; Neri, Dario.

Afiliação

Bassi G; Small Molecule Therapeutics Department, Philochem AG, Libernstrasse 3, 8112, Otelfingen, Switzerland. gabriele.bassi@philochem.ch.
Cazzamalli S; Small Molecule Therapeutics Department, Philochem AG, Libernstrasse 3, 8112, Otelfingen, Switzerland. samuele.cazzamalli@philochem.ch.
Oehler S; Small Molecule Therapeutics Department, Philochem AG, Libernstrasse 3, 8112, Otelfingen, Switzerland.
Lucaroni L; Small Molecule Therapeutics Department, Philochem AG, Libernstrasse 3, 8112, Otelfingen, Switzerland.
Georgiev T; Small Molecule Therapeutics Department, Philochem AG, Libernstrasse 3, 8112, Otelfingen, Switzerland.
Favalli N; Small Molecule Therapeutics Department, Philochem AG, Libernstrasse 3, 8112, Otelfingen, Switzerland.
Neri D; Small Molecule Therapeutics Department, Philochem AG, Libernstrasse 3, 8112, Otelfingen, Switzerland. dario.neri@philogen.com.

Eur J Nucl Med Mol Imaging ; 50(10): 2947-2949, 2023 08.

Article em En | MEDLINE | ID: mdl-37341746

Assuntos

Glutamato Carboxipeptidase II; Ureia; Humanos; Ligantes; Antígenos de Superfície; Linhagem Celular Tumoral

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ureia / Glutamato Carboxipeptidase II Limite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google